Showing 411-420 of 3172 results for "".
Journal Scan of Three Trials for an Rx Option
https://practicaldermatology.com/topics/psoriasis/deucravacitinib-journal-scan/29155/A review of three clinical trials, with introduction and commentary by Linda Stein Gold, MD. Click the image to download the full supplement.Advances in Topicals for Skin Conditions
https://practicaldermatology.com/topics/psoriasis/advances-in-topicals-for-skin-conditions/20197/There are more topicals available today than ever before for acne, rosacea, and psoriasis, and even more are coming down the pike. Larry Green, MD, reviews the current topical landscape in dermatology and previews what’s in the pipeline.Scientifically Speaking: The Expanded Role for Microneedling
https://practicaldermatology.com/series/scientifically-speaking/the-expanded-role-for-microneedling/20011/What's the role for microneedling in today's practice? What are the best strategies to optimize outcomes? In this edition of Scientifically Speaking, host Joel L. Cohen, MD gathers expert insights from Anna Guanche, MD; Mara Weinstein Velez, MD; and Doris Day, MD.DermWireTV: Barbie Gets Inclusive, Hacking Prizes, Maui Derm Updates
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-barbie-gets-inclusive-hacking-prizes-maui-derm-updates/19738/Mattel has introduced several new dolls as part of its "Fashionista" line for 2020, including a doll with alopecia and one with vitiligo. Jeanine Downie, MD weighs in. Maui Derm 2020 offers insights on new and emerging therapies for acne, skincancer, and more. Hacking Dermatology has a winner.Hot Topic: Picture Perfect
https://practicaldermatology.com/topics/practice-management/hot-topic-picture-perfect/19567/Standardizing before and after photos in your practice is a must, explains Todd E. Schlesinger, MD. He sits down with Joel L. Cohen, MD to offer tips on improving the quality of photos from what type of camera to use to standardizing camera settings, the angle of photos, and the backdrop used.eRelevance Uncovers Marketing Truths, EADV Data, Primetime for Botox
https://practicaldermatology.com/series/dermwire-tv/erelevance-uncovers-marketing-truths-eadv-data-primetime-for-botox/18429/The State of Aesthetic Healthcare Marketing 2017 from eRelevance shows that nearly 60 percent of aesthetic physicians say they either don't see results from their marketing initiatives or aren't able to measure results. Data presented at the annual meeting of the European Academy of Dermatology andMeaningful Approaches to Vitiligo
https://practicaldermatology.com/topics/general-topics/meaningful-approaches-to-vitiligo/18599/As science continues to uncover more about vitiligo and its treatment, dermatologists have more options than ever. But there's still work to be done. In this edition of Ask an Expert, host Adam Friedman, MD talks to John E. Harris, MD, PhD, Director of the Vitiligo Clinic and Research Center at UnivTo Be Shorr: Importance of Using Technology to Its Fullest Extent
https://practicaldermatology.com/topics/practice-management/to-be-shorr-importance-of-using-technology-to-its-fullest-extent/18605/Some of the administrative tasks that bog down a practice can be automated—and your existing vendors may have the applications and technology you need to make it happen. Be sure to investigate the services your vendors provide, many of which you already pay for, to make the most of your practice tecOn the Leading Edge, Not the Bleeding Edge: Joe Niamtu, DMD
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/on-the-leading-edge-not-the-bleeding-edge-joe-niamtu-dmd/18606/Innovator, influencer, and podium perennial Joe Niatmu, III, DMD has built a successful surgical aesthetic practice by focusing on the basics, concentrating on his strengths, and avoiding passing fads. How does he stay passionate, spot the best new developments, and build a fulfilling practice? In tValeant Acquires Salix; Actavis Changing Name
https://practicaldermatology.com/series/dermwire-tv/valeant-acquires-salix-actavis-changing-name/18963/Valeant expands its portfolio with the acquisition of GI market leader Salix. Actavis divests Doryx and considers a name change to Allergan. Kythera acquires rights for investigational hair therapies. And Cynosure's 532nm laser delivery system is FDA cleared for PicoSure.